GSR III Acquisition Corp. Class A GSRT 深 滬
等待開盤 10-09 09:30:00 美东时间
14.52
+2.520
+21.00%
華盛通- 最 高14.91
- 今 開12.42
- 成交量 325.97万股
- 最 低 12.22
- 昨 收 12.00
- 總市值 4.24亿
- 52周最高 14.91
- 市盈率 靜 446.77
- 換手率 11.17%
- 52周最低 8.82
- 委 比 43.08%
- 總股本 2917.25万
- 歷史最高 14.91
- 量 比 0.86
- 振 幅 22.42%
- 歷史最低 8.82
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Terra Innovatum and GSR III Acquisition Corp. Announce Shareholder Approval of Business Combination with $130 Million of Total Proceeds Expected at Close
Terra Innovatum, a developer of micro-modular nuclear reactors, announced the approval of its business combination with GSR III Acquisition Corp., securing $130 million in financing to advance its SOLO™ reactor's licensing, production, and deployment. The capital-light business model and strong cash position are expected to drive growth, commercial scale-up, and supply chain enhancements. The company's shares will trade on Nasdaq under the symbol...
10-07 16:30
GSR III Shareholders Retain Shares Amid Business Combination
GSR III Acquisition Corp. Class A ( ($GSRT) ) has issued an update. On October ...
10-06 21:49
Terra Innovatum is Accelerating Plans to Advance its Strategic Position in the Rapidly Growing Radioisotope Market by Producing Life-Saving Cancer Isotopes
Terra Innovatum's SOLO™ micro-modular reactor is designed to revolutionize global healthcare by enabling decentralized, localized production of medical isotopes. This innovative solution addresses the challenges of relying on centralized nuclear reactors, which face issues such as aging infrastructure and supply chain vulnerabilities. SOLO™ can produce critical isotopes like molybdenum-99, technetium-99m, and cobalt-60, supporting diagnostics and...
10-02 12:00
Terra Innovatum Announces Strategic Alliance with Defense Engineering Center, RAIT 88, to Accelerate Global Commercialization of SOLO™ Micro-Modular Nuclear Reactors
Terra Innovatum and RAIT 88 have signed an MOU to advance the commercialization of Terra’s SOLO™ micro-modular nuclear reactors for defense, civil energy, and government sectors. The collaboration leverages RAIT 88’s expertise in engineering, R&D, and NATO networks to enhance deployment, operations, and training of MMR systems. Early-stage tests are scheduled, with potential projects targeting over 1 GWe of capacity across Europe and Asia. Both p...
09-30 13:22
Terra Innovatum Partners with Ameresco to Jointly Pursue Public-Private Commercial Opportunities in the U.S. and Global Markets to Deploy SOLO Micro-Modular Reactors
Terra Innovatum and Ameresco partner to deploy 50 SOLO™ micro-modular nuclear reactors across U.S. federal and commercial sites, leveraging Ameresco's expertise and network. The collaboration aims to accelerate the commercial rollout of SOLO™ reactors, which provide safe, scalable, and carbon-free energy solutions for various applications, including power generation and industrial processes. The reactors are designed for rapid deployment and offe...
09-29 12:00
Terra Innovatum and GSR III Acquisition Corp. Announce $37.5 Million Equity Financing in Connection with Business Combination
<p align="center">- PIPE led by Segra Capital Management</p> <p align="center">- Proceeds from the financing and SPAC trust, net of redemptions and expenses, will be used to support licensing and construction of Terra Innovatum’s first-of-a-kind SOLO™ micro-modular reactor</p> <p align="center">- Extraordinary general meeting of shareholders to approve proposed business combination is scheduled for October 7, 2025, at 11:00 a.m. ET</p> <p align="...
09-25 12:00
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
Roth Capital Initiates Coverage On GSR III Acquisition with Buy Rating, Announces Price Target of $20
Roth Capital analyst Craig Irwin initiates coverage on GSR III Acquisition (NASDAQ:GSRT) with a Buy rating and announces Price Target of $20.
09-24 00:58
Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO™ Reactor
Terra Innovatum is advancing its collaboration with the U.S. Nuclear Regulatory Commission (NRC) to expedite licensing and aim for commercialization of its SOLO™ micro-modular reactor by 2028. Key milestones in 2025 include submitting regulatory documents, initiating discussions on fuel use, environmental reports, safety analysis, and deployment planning. The company expects NRC reviews to complete by year-end, with a PSAR submission in 2026, con...
09-22 12:00
Terra Innovatum Signs Supplier MOU with Conuar for Key SOLO Micro-Modular Reactor Components
Terra Innovatum and Conuar have signed an MOU for critical components in producing the SOLO micro-modular reactor, enhancing supply chain resilience and targeting Latin American markets. The collaboration includes developing a supply chain hub and assembly lines in South America. SOLO offers scalable, clean energy solutions for remote and industrial applications, with potential to deliver scalable power and essential radioisotopes.
09-16 12:00
